X
Lilly joins CGRP race to cure migraine
https://pharmaphorum.com/news/lilly-joins-cgrp-race-to-cure-migraine/
Eli Lilly
Lilly drug scrapes through cluster headache trial
FDA to make decision on Amgen drug tomorrow
Lilly buys cancer biotech ARMO for $1.6bn
Lilly adds pancreatic cancer drug to pipeline
Lilly and Alder showcase latest migraine drug data
Lilly and Alder take on the might of Novartis and Amgen
Trulicity helps SGLT-2 patients lower blood sugar
New phase 3b trial results show Lilly’s Trulicity combined with an SGLT2 inhibitor failed to show any benefits above and beyond Trulicity’s blood glucose lowering.
